INOFEA spins-off Perseo Pharma to further develop therapeutic enzymes

The Basel based Inofea AG has founded Perseo pharma AG as spin-off for therapeutic applications. The objective is to develop a new line of therapeutic enzymes based on Inofea’s innovative, unique and patent protected enzyme shielding technology. Perseo has already secured capital from business angels.